| Dr Paul James Dietze, MD | |
|
715 N Kansas Ave Ste 300, Hastings, NE 68901-4452 | |
| (402) 462-9009 | |
| (402) 462-8090 |
| Full Name | Dr Paul James Dietze |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 37 Years |
| Location | 715 N Kansas Ave Ste 300, Hastings, Nebraska |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073525838 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 17684 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brodstone Memorial Hosp | Superior, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Geiger And Dietze Ophthalmology | 3173567989 | 2 |
News Archive
The European Society for Medical Oncology, the leading professional organization for medical oncology in Europe, proudly announced that medical oncology has been included among the medical specialties covered by Directive 2005/36/EC on the recognition of professional qualifications, as announced yesterday by the Commission.
A strategy where living kidney donors are paid $10,000, with the assumption that this strategy would increase the number of transplants performed by 5% or more, would be less costly and more effective than the current organ donation system, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
Patients who received automated telephone calls inviting them to get their blood pressure checked at a walk-in clinic were more likely to have controlled hypertension than patients who did not receive calls, according to a Kaiser Permanente study published today in the Journal of Clinical Hypertension.
Osteonecrosis of the jaw is a debilitating bone condition that affects the jaws and occurs as a result of reduced local blood supply to the bone. The literature in this area has been severely limited since most investigations cannot evaluate sufficient numbers of afflicted individuals to accurately determine the incidence of the disease and associated risk factors.
Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the results from their real-world study XALIA showing that, in people with deep vein thrombosis (DVT), the rates of major bleeding and recurrent blood clots for XARELTO (rivaroxaban) in routine clinical practice were generally consistent with those observed in Phase 3 research.
› Verified 1 days ago
| Entity Name | Geiger & Dietze Ophthalmology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689771289 PECOS PAC ID: 3173567989 Enrollment ID: O20050613001164 |
News Archive
The European Society for Medical Oncology, the leading professional organization for medical oncology in Europe, proudly announced that medical oncology has been included among the medical specialties covered by Directive 2005/36/EC on the recognition of professional qualifications, as announced yesterday by the Commission.
A strategy where living kidney donors are paid $10,000, with the assumption that this strategy would increase the number of transplants performed by 5% or more, would be less costly and more effective than the current organ donation system, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
Patients who received automated telephone calls inviting them to get their blood pressure checked at a walk-in clinic were more likely to have controlled hypertension than patients who did not receive calls, according to a Kaiser Permanente study published today in the Journal of Clinical Hypertension.
Osteonecrosis of the jaw is a debilitating bone condition that affects the jaws and occurs as a result of reduced local blood supply to the bone. The literature in this area has been severely limited since most investigations cannot evaluate sufficient numbers of afflicted individuals to accurately determine the incidence of the disease and associated risk factors.
Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the results from their real-world study XALIA showing that, in people with deep vein thrombosis (DVT), the rates of major bleeding and recurrent blood clots for XARELTO (rivaroxaban) in routine clinical practice were generally consistent with those observed in Phase 3 research.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul James Dietze, MD 715 N Kansas, Suite 300, Hastings, NE 68901-4452 Ph: (402) 462-9009 | Dr Paul James Dietze, MD 715 N Kansas Ave Ste 300, Hastings, NE 68901-4452 Ph: (402) 462-9009 |
News Archive
The European Society for Medical Oncology, the leading professional organization for medical oncology in Europe, proudly announced that medical oncology has been included among the medical specialties covered by Directive 2005/36/EC on the recognition of professional qualifications, as announced yesterday by the Commission.
A strategy where living kidney donors are paid $10,000, with the assumption that this strategy would increase the number of transplants performed by 5% or more, would be less costly and more effective than the current organ donation system, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
Patients who received automated telephone calls inviting them to get their blood pressure checked at a walk-in clinic were more likely to have controlled hypertension than patients who did not receive calls, according to a Kaiser Permanente study published today in the Journal of Clinical Hypertension.
Osteonecrosis of the jaw is a debilitating bone condition that affects the jaws and occurs as a result of reduced local blood supply to the bone. The literature in this area has been severely limited since most investigations cannot evaluate sufficient numbers of afflicted individuals to accurately determine the incidence of the disease and associated risk factors.
Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the results from their real-world study XALIA showing that, in people with deep vein thrombosis (DVT), the rates of major bleeding and recurrent blood clots for XARELTO (rivaroxaban) in routine clinical practice were generally consistent with those observed in Phase 3 research.
› Verified 1 days ago
Dr. John C Welch, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6003 Osborne Dr W, Hastings, NE 68901 Phone: 402-461-4611 Fax: 402-461-4616 | |
Dr. Gerald Francis Geiger, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 715 N Kansas, Suite 300, Hastings, NE 68901 Phone: 402-462-9009 Fax: 402-462-8090 | |
Dr. William D. Terrell, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6003 Osborne Dr W, Hastings, NE 68901 Phone: 402-461-4611 Fax: 402-461-4616 | |
Dr. Harry Nicholas Vondrak, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1414 W 12th St, Hastings, NE 68901 Phone: 402-462-9191 Fax: 402-462-9192 |